H.C. Liang

Type de document

Co-auteur

M.W. Zimmerman

F. Zammarchi

W. Woessmann

J. Wallwitz

S.D. Turner

S. Tangermann

S. Stoiber

D. Stoiber

I. Simonitsch-Klupp

D.A. Silva

D. Sibon

N. Schleussner

N. Prutsch

N. Prokoph

S. Pospisilova

S. Pileri

S. Pervez

J. Oppelt

I.A. Montes-Mojarro

O. Merkel

S. Mathas

A.T. Look

C. Lobello

F. Knörr

W. Klapper

L. Kenner

M. Janz

A. Janiková

T. Hielscher

E. Gurnhofer

P Gaulard

K.C. Garcia

F. Fend

V. Fataccioli

L. De Leval

C. Damm-Welk

M. Costanza

L. Cerroni

D. Baker

C. Assaf

I. Anagnostopoulos

B.J. Abraham

Date

Source

Serveur académique Lausannois (1)

Mot-clé

biologie (1) thérapie (1) état (1) acide nucléïque (1) modèle (1) ligne (1) Treatment (1) Identification (1) Genes (1) Interleukin-2 (1) Transcription (1) Tops (1) Therapeutics (1) Strategy (1) Prognosis (1) Patients (1) Mice (1) Human beings (1) Lymphomas (1) Identification (1) Growth (1) Governors (Machinery) (1) Genetic regulation (1) Expression (1) Example (1) Cells (1) Breast (1) Biology (1) Animals (1) Addition (1)

Documents écrit par H.C. Liang (1) | parle de H.C. Liang (0)

Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.

H.C. Liang et al. (22 sept. 2021)